DNA Repair Deficiency and Immunotherapy Response
Authors:
- 10 June 2018
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 36 (17) , 1710-1713
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Whole-Exome Sequencing of Muscle-Invasive Bladder Cancer Identifies Recurrent Mutations of UNC5C and Prognostic Importance of DNA Repair Gene Mutations on SurvivalClinical Cancer Research, 2014
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine, 2014
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial CarcinomaCancer Discovery, 2014
- Mechanisms underlying mutational signatures in human cancersNature Reviews Genetics, 2014
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial CancerScience, 2014
- Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology, 2013
- Signatures of mutational processes in human cancerNature, 2013
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaLaboratory Investigation, 2012
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006